Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma

Lenvatinib is a first-line standard treatment for advanced hepatocellular carcinoma (HCC) with better anti-tumor effects than sorafenib, as shown by greater inhibition of the kinases of fibroblast growth factor receptor and vascular endothelial growth factor (VEGF) receptor. This report describes a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Gastroenterol
Main Authors: Suzuki, Naomi, Tajiri, Kazuto, Futsukaichi, Yuka, Tanaka, Shinichi, Murayama, Aiko, Entani, Toshiki, Kobayashi, Saito, Takahashi, Kosuke, Fujii, Tsutomu, Imura, Johji, Yasuda, Ichiro
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2020
Assuntos:
Single Case
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7036537/
https://ncbi.nlm.nih.gov/pubmed/32110202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505774
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados